InvestorsHub Logo
Followers 3
Posts 582
Boards Moderated 0
Alias Born 01/19/2012

Re: None

Thursday, 04/19/2018 3:41:59 PM

Thursday, April 19, 2018 3:41:59 PM

Post# of 7574



Multiple upcoming catalysts could see GERN shares soar into the teen or higher. For JNJ, Imetelstat may soon join the ranks of their mega-blockbuster drugs with worldwide sales of $4 billion per year and above, yielding sizable gains for shareholders.
https://seekingalpha.com/article/4164027-johnson-and-johnson-reaffirms-gerons-imetelstat-lead-oncology-pipeline-drug
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News